Amanda Sheldon
Vice President, Investor Relations
Replay available
Arcutis Biotherapeutics, Inc. (ARQT) Q1 2025 Earnings Call
Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) Q1 2025 earnings conference call, held 2025-05-06. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Latha Virovan
Chief Financial Officer
Patrick Burnett
Chief Medical Officer
Frank Watanabe
President and Chief Executive Officer
Todd Edwards
Chief Commercial Officer
Tyler Van Buren
Analyst, TD Cowen
Serge Bellinger
Analyst, Needham & Company
Kanbiz Yazdi
Analyst, Jefferies
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Arcutis Biotherapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.859 Good day, and welcome to Arcudis Biotherapeutics 2025 First 00:00:05.859 -- 00:00:09.184 Quarter Financial Results Conference Call. 00:00:09.184 -- 00:00:13.850 At this time, all participants are in the listen-only mode. 00:00:13.850 -- 00:00:18.837 After the speaker's presentation, there will be a question and answer session. 00:00:18.837 -- 00:00:22.221 Please be advised that today's conference is being recorded. 00:00:22.221 -- 00:00:26.407 I would now like to hand the call over to Amanda Sheldon. 00:00:26.407 -- 00:00:27.328 Please go ahead. 00:00:27.328 -- 00:00:32.369 Thank you, Heidi. Good afternoon, everyone, and thank you for joining us today to 00:00:32.369 -- 00:00:37.077 review our first quarter 2025 financial results and business update. 00:00:37.077 -- 00:00:42.045 Slides for today's call are available on the investor section of the Arcutus website. 00:00:42.045 -- 00:00:47.413 On the call today are Frank Watanabe, President and CEO, Patrick Burnett, 00:00:47.413 -- 00:00:53.062 Chief Medical Officer, Todd Edwards, Chief Commercial Officer, and Latha 00:00:53.062 -- 00:00:58.190 Virovan, Chief Financial Officer. I'd like to remind everyone that we will 00:00:58.190 -- 00:01:01.394 be making forward-looking statements during this call. 00:01:01.394 -- 00:01:05.820 These statements are subject to certain risks and uncertainties, and our actual results 00:01:05.820 -- 00:01:10.306 may differ. We encourage you to review all the company's filings with the Securities 00:01:10.306 -- 00:01:14.752 and Exchange Commission, including descriptions of our business and risk factors. 00:01:14.752 -- 00:01:17.576 With that, let me hand the call over to Frank. 00:01:17.576 -- 00:01:21.622 Thank you, Amanda, and thank you to everyone ...